Wondering what the changing NHS landscape could mean for patients, services, and clinical pathways? Merck UK & Ireland are excited to announce their new podcast series, NAVIGATE! NAVIGATE aims to educate listeners on the changing UK healthcare landscape and provide NHS stakeholders with recommendations on how they can support the optimal delivery of care in the fast-emerging integrated care landscape. Throughout this series, our Director of Market Access, Amerah Amin, will be joined by several leading experts from across the NHS, to explore different views on how service delivery is evolving in the NHS across a number of conditions, ranging from cancer to neurology care. In doing so, we will consider what exactly emerging Integrated Care Systems (ICSs) could mean for the NHS and the communities and individuals they serve. Stay tuned to catch future episodes of NAVIGATE and be part of this important conversation with Merck!
https://mercknavigate.podbean.com
episode 1: What could the future of Multiple Sclerosis Services look like? A NAVIGATE podcast
Wondering what the changing NHS landscape could mean for patients, services, and clinical pathways? Merck UK & Ireland are excited to announce their new podcast series, NAVIGATE!
NAVIGATE aims to educate listeners on the changing UK healthcare landscape and provide NHS stakeholders with recommendations on how they can support the optimal delivery of care in the fast-emerging integrated care landscape.
Throughout the series we will be joined by leading experts from across the NHS to explore views on how care is evolving across a range of conditions - from cancer to neurology services.
In our first episode we are delighted to talk to Julie Riley, Director of Operations for Neurology at the Walton Centre and Dr Mark Cossburn, Consultant Neurologist at North Bristol NHS Trust. We sit down (virtually) with Julie and Mark to discuss how the delivery of Multiple Sclerosis (MS) services could evolve in the future.